Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

This study is ongoing, but not recruiting participants.

Study NCT00462215 Information provided by Baxter Healthcare Corporation

First Received: April 17, 2007 Last Updated: July 21, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	November 2009
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)